Eliem Therapeutics (ELYM)
(Delayed Data from NSDQ)
$7.66 USD
+0.25 (3.37%)
Updated May 28, 2024 04:00 PM ET
After-Market: $7.65 -0.01 (-0.13%) 7:56 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Eliem Therapeutics, Inc. [ELYM]
Reports for Purchase
Showing records 1 - 5 ( 5 total )
Company: Eliem Therapeutics, Inc.
Industry: Medical - Drugs
Company: Eliem Therapeutics, Inc.
Industry: Medical - Drugs
Eliem Therapeutics? 4Q22 in Numbers; Maintain Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Eliem Therapeutics, Inc.
Industry: Medical - Drugs
Eliem Puts ETX-155 on Back Burner; Downgrade to Neutral; PT Under Review
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Eliem Therapeutics, Inc.
Industry: Medical - Drugs
Company: Eliem Therapeutics, Inc.
Industry: Medical - Drugs
A Fast Follower in GABA and Kv7 Can Drive Significant Value; Initiate at Buy With $6 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
|